Literature DB >> 3145891

Laboratory diagnosis of Mycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay.

T W Kok1, G Varkanis, B P Marmion, J Martin, A Esterman.   

Abstract

Direct and indirect antigen capture enzyme immunoassays (Ag-EIA) have been developed for the detection of Mycoplasma pneumoniae in nasopharyngeal aspirates or sputum from respiratory infection. The sensitivity of the two Ag-EIA were similar, but the indirect method using polyclonal rabbit and guinea-pig antisera was more convenient. The Ag-EIA had a detection limit of 10(4-4.5) colony-forming units/ml of sample. It was specific for M. pneumoniae and gave a low level response with M. genitalium. There were no cross-reactions with 10 other species of mycoplasmas. Tests with a wide range of bacteria and chlamydia group antigen, representing agents sometimes found in the respiratory tract, were also negative. At the current level of development, the Ag-EIA detected about 90% of specimens that were also positive for culture; 43% of specimens from culture-negative--seropositive patients gave a positive result. The overall pattern of results indicated that while antigen detection is a quick and effective substitute for the slow culture method, serological examination for specific IgM antibody is also necessary to give a complete diagnostic coverage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145891      PMCID: PMC2249410          DOI: 10.1017/s0950268800029551

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  26 in total

1.  AN INDIRECT HEMAGGLUTINATION TEST FOR DIAGNOSIS OF MYCOPLASMA PNEUMONIAE INFECTIONS.

Authors:  W R DOWDLE; R Q ROBINSON
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

2.  Appearance of Mycoplasma pneumoniae in lungs of experimentally infected hamsters and sputum from patients with natural disease.

Authors:  A M Collier; W A Clyde
Journal:  Am Rev Respir Dis       Date:  1974-12

3.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

4.  Infection with Mycoplasma pneumoniae in civilians in the Netherlands.

Authors:  J F Hers; N Masurel
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

5.  Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1971-12

6.  Acute respiratory disease associated with pulmonary involvement in military servicement in The Netherlands. A serologic and bacteriologic survey, January 1967 to January 1968.

Authors:  J F Hers; N Masurel; J C Gans
Journal:  Am Rev Respir Dis       Date:  1969-10

7.  Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection.

Authors:  D Taylor-Robinson; O Sobĕslavsyý; K E Jensen; L B Senterfit; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

8.  Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids.

Authors:  P Plackett; B P Marmion; E J Shaw; R M Lemcke
Journal:  Aust J Exp Biol Med Sci       Date:  1969-04

9.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma.

Authors:  J G Tully; R F Whitcomb; H F Clark; D L Williamson
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

10.  The mechanism of indction of cold agglutinins by mycoplasma pneumoniae.

Authors:  N Costea; V J Yakulis; P Heller
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

View more
  20 in total

1.  Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification.

Authors:  K Loens; M Ieven; D Ursi; T Beck; M Overdijk; P Sillekens; H Goossens
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Post-infectious encephalomyelitis associated with Mycoplasma pneumoniae and Legionella pneumophila infection.

Authors:  P J Easterbrook; E G Smyth
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

3.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Isolation of Mycoplasma genitalium strains from the male urethra.

Authors:  J S Jensen; H T Hansen; K Lind
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Rapid immunoblot method for diagnosis of acute Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Thomas; P J Middleton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections.

Authors:  W L Thacker; D F Talkington
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Laboratory diagnosis of Mycoplasma pneumoniae infection. 3. Detection of IgM antibodies to M. pneumoniae by a modified indirect haemagglutination test.

Authors:  T W Kok; B P Marmion; G Varkanis; D A Worswick; J Martin
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

10.  Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction.

Authors:  L Skakni; A Sardet; J Just; J Landman-Parker; J Costil; N Moniot-Ville; F Bricout; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.